cfDNA

Advancing Methylation Analysis with Reliable DNA Extraction

By

A recent study in Clinical Epigenetics (Nuttall et al., 2025) shows that enzymatic methylation sequencing delivers higher-quality, more reliable results than traditional methods across challenging clinical samples. Powered by high-purity DNA extraction from Omega Bio-tek’s Mag-Bind® kits, the workflow enabled advanced whole-genome methylation insights and revealed new biomarkers linked to treatment response in leukemia.

Advancing Methylation Analysis with Reliable DNA Extraction Read More »

Plasma cfDNA Methylation Profiling for Lung Cancer Detection Using Targeted EM-seq

By

This Scientific Reports study demonstrates how integrating cfDNA methylation patterns with fragment size analysis enables highly sensitive, non-invasive detection of lung cancer from plasma samples. By providing high-quality cfDNA isolation for targeted EM-seq workflows, Omega Bio-tek’s Mag-Bind® cfDNA Kit supports the precision and reliability required for advanced liquid biopsy diagnostics.

Plasma cfDNA Methylation Profiling for Lung Cancer Detection Using Targeted EM-seq Read More »

Ultra-Sensitive Cancer Monitoring from Plasma cfDNA Using Genome-Wide Sequencing

By

This Nature Medicine study demonstrates that genome-wide integration of tumor mutations in plasma cell-free DNA enables ultra-sensitive detection of minimal residual disease and early recurrence—down to tumor fractions as low as 10⁻⁵. By using high-quality cfDNA isolated with the Mag-Bind® cfDNA Kit, researchers ensured optimal fragment recovery and consistency, supporting the reliable whole-genome sequencing workflows that made this breakthrough in cancer monitoring possible.

Ultra-Sensitive Cancer Monitoring from Plasma cfDNA Using Genome-Wide Sequencing Read More »

Shopping Cart
Scroll to Top